China’s Role in ICH E17 MRCT Guidelines Implementation
China’s Role in ICH E17 MRCT Guidelines Implementation China’s Contribution to Implementing ICH E17 MRCT Guidelines Introduction The International Council for Harmonisation (ICH) E17 guideline on multi-regional clinical trials (MRCTs) has reshaped global drug development, encouraging efficient, harmonized trials that support simultaneous submissions across regions. China, under the National Medical Products Administration (NMPA), has emerged…
Read More “China’s Role in ICH E17 MRCT Guidelines Implementation” »